General
June 15, 2024
Source: PERS
The Medical City Debuts Philippines' First Moses 2.0 Laser for Advanced Urological Care
— The Medical City (TMC) has reached a new milestone in Philippine healthcare by becoming the first hospital in the country to acquire and utilize the Lumenis Moses 2.0 Holmium Laser technology. This state-of-the-art advancement, officially launched in late 2024, represents a significant leap forward in the minimally invasive treatment of kidney stones and benign prostatic hyperplasia (BPH).
Revolutionizing Stone and Prostate Treatment
The Moses 2.0 technology introduces a unique pulse modulation that optimizes energy delivery to the target. This innovation addresses long-standing challenges in urological surgery, such as stone retropulsion (the movement of stones away from the laser), which often complicates procedures and extends surgery times.
- Enhanced Precision: The "Moses Effect" creates a vapor bubble that paves the way for the laser energy to reach the stone or tissue more effectively.
- Reduced Retropulsion: Clinical data shows up to a 50% reduction in retropulsion, preventing "stone chasing" and ensuring the laser remains focused on the target.
- Faster Procedures: The technology can reduce fragmentation time by approximately 33% and overall procedure time by nearly 20%.
Patient-Centered Benefits
For patients at The Medical City, the adoption of Moses 2.0 translates into safer outcomes and faster recoveries. The tool’s precision allows for "delicate procedures with minimal discomfort and maximum effectiveness".
Key patient benefits include:
- Faster Recovery: Most BPH patients treated with this technology can be discharged on the same day.
- Minimally Invasive: The procedure requires no large incisions, leading to less pain and reduced bleeding.
- Reduced Need for Stents: The advanced "dusting" technique often eliminates the need for post-operative stents or stone-retrieval baskets.
